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Abstract
Background: The Canadian Perinatal Network (CPN) was launched
in 2005 as a national perinatal database project designed to
identify best practices in maternity care. The inaugural project of
CPN is focused on interventions that optimize maternal and
perinatal outcomes in women with threatened preterm birth at
22+0 to 28+6 weeks’ gestation.
Objective: To examine existing data collection by perinatal health
programs (PHPs) to inform decisions about shared data collection
and CPN database construction.
Methods: We reviewed the database manuals and websites of all
Canadian PHPs and compiled a list of data fields and their
definitions. We compared these fields and definitions with those of
CPN and the Canadian Minimal Dataset, proposed as a common
dataset by the Canadian Perinatal Programs Coalition of
Canadian PHPs.
Results: PHPs collect information on 2/3 of deliveries in Canada.
PHPs consistently collect information on maternal demographics
(including both maternal and neonatal personal identifiers), past
obstetrical history, maternal lifestyle, aspects of labour and
delivery, and basic neonatal outcomes. However, most PHPs
collect insufficient data to enable identification of obstetric (and
neonatal) practices associated with improved maternal and
perinatal outcomes. In addition, there is between-PHP variability in
defining many data fields.
Conclusion: Construction of a separate CPN database was needed,
although harmonization of data field definitions with those of the
proposed Canadian Minimal Dataset was done to plan for future
shared data collection. This convergence should be the goal of
researchers and clinicians alike as we construct a common
language for electronic health records.
Résumé
Contexte : Le Réseau périnatal canadien (RPC) a été lancé en 2005
en tant que projet national de base de données périnatale conçue
pour identifier les pratiques optimales en matière de soins de
maternité. Le projet inaugural du RPC est axé sur les interventions
qui optimisent les issues maternelles et périnatales chez les
femmes qui présentent une menace d’accouchement préterme à
22+0 à 28+6 semaines de gestation.
Objectif : Examiner les systèmes existants de collecte de données
par des programmes de santé périnatale (PSP) en vue d’éclairer
les décisions au sujet de la collecte commune de données et de la
construction de la base de données RPC.
Méthodes : Nous avons analysé les sites Web et les manuels de
base de données de tous les PSP canadiens, et compilé une liste
de champs de données et de leurs définitions. Nous avons
comparé ces champs et ces définitions avec ceux du RPC et du
Canadian Minimal Dataset, lequel a été proposé en tant
qu’ensemble de données commun par le Partenariat des
programmes périnatals du Canada des PSP canadiens.
Résultats : Les PSP recueillent des données sur les 2/3 des
accouchements au Canada. Les PSP recueillent régulièrement de
l’information sur les caractéristiques démographiques maternelles
(y compris les identificateurs personnels de la mère et du
nouveau-né), les antécédents obstétricaux, le mode de vie
maternel, les aspects du travail et de l’accouchement, et les
issues néonatales de base. Cependant, la plupart des PSP ne
recueillent pas suffisamment de données pour permettre
l’identification des pratiques obstétricales (et néonatales)
associées à l’amélioration des issues maternelles et périnatales.
De plus, on a constaté une variabilité inter-PSP pour ce qui est de
la définition de nombreux champs de données.
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Conclusion : La construction d’une base de données RPC distincte
s’est avérée requise; cependant, nous avons procédé à
l’harmonisation des définitions de champ de données avec celles
du Canadian Minimal Dataset proposé de façon à préparer une
future mise en commun de la collecte de données. Cette
convergence devrait être l’objectif tant des chercheurs que des
cliniciens au fur et à mesure que nous bâtissons une langue
commune pour ce qui est des dossiers de santé électronique.
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INTRODUCTION
In Canada, more than 350 000 babies are born each year.Preterm birth complicates 7.6% of births, with variations
of 
15% between provinces.1 Despite improvements in
prenatal care, preterm birth is still the most important cause
of perinatal mortality and morbidity, and it is recognized to
hold the greatest potential for improved outcomes.1
While it is certain that obstetric practice can influence neo-
natal outcomes, there are many controversies around the
care of women at risk for very preterm delivery. The inau-
gural project of the Canadian Perinatal Network is to iden-
tify, in the context of threatened very preterm births at
22+0 to 28	6 weeks’ gestation, interventions that are
related to good or poor maternal and perinatal outcomes
and to greater or lesser resource use. This requires collec-
tion of detailed information about obstetric practices,
which CPN hopes eventually to collect from all 24 tertiary
perinatal units in Canada. CPN also links with the
well-established Canadian Neonatal Network and Canadian
Perinatal Surgery Network.
Many tertiary perinatal units collect data as part of a provin-
cial perinatal health program. These programs have been set
up to monitor geographical disparities in perinatal health
and in determinants of adverse outcomes (e.g., low socio-
economic status). Much of this information is used for
regional reporting to governments and policy makers; how-
ever, this is only a portion of the larger mandate of the
PHPs. The mandate also includes peer review, education,
and guideline development. We analyzed the breadth of
data collection by Canadian PHPs in the hope of harmoniz-
ing their data collection with that of CPN. Presented here is
a detailed analysis of existing data collection by Canadian
PHPs.
METHODS
Information about PHPs was gathered from websites, pro-
vincial reports, and one-on-one communication with
coordinators. With the assistance of representatives at the
BCPHP, we contacted the coordinators from existing
PHPs, and then requested and received electronic manuals
for their databases. From these manuals, each data field and
its definition were recorded to form a master table. This
table was sent to the coordinators of each of the provincial
PHPs to confirm accuracy of the PHP data collection. This
included clarifying which data fields were collected from the
medical record and which were obtained from the Canadian
Institute for Health Information database, which includes
demographics, ICD-10 diagnoses, and procedures.
The information in the table was organized into the follow-
ing categories: demographics; past medical, obstetric, and
surgical history; current pregnancy; maternal complications
and interventions; fetal complications and interventions;
labour and delivery; and perinatal outcomes.
For the purposes of comparison, our analysis includes data
fields and definitions from the Canadian Minimal Dataset
proposed by the Canadian Perinatal Programs Coalition2
and the CPN Database (May 2008 version).3
The Canadian Perinatal Programs Coalition Database Com-
mittee was created in 1988 and aims to serve as a vehicle for
the exchange of ideas and information between profession-
als involved in the PHPs. At present, each province with a
PHP collects its own data, but the CPPC is in the process of
determining how and what could be shared nationally, while
still satisfying each province’s needs and privacy concerns.
The CPPC recognizes both the variability in the informa-
tion collected and the lack of standardized definitions.
The CPPC has proposed a CMDS, and the provinces are
currently comparing their respective databases to the
CMDS. Each will make a commitment as to when they will
be in compliance with the CMDS.2
Although there are a variety of regional databases, for
example Southwestern Ontario Perinatal Partnership, we
included only provincial perinatal initiatives. It is also
important to note that there are other provincial networks,
such as the Fetal Alert Network in Ontario, which focus on
birth defects and prenatal screening. Quebec, Saskatchewan,
Northwest Territories, Nunavut, New Brunswick, and
Manitoba were not included because none of them have a
functional reproductive care database, although some are in
the process of establishing one.
RESULTS
Since 2004, PHPs have collectively covered two thirds of
births in Canada, with perinatal data collection beginning as
early as 1988 by the Nova Scotia Atlee Perinatal Database.
The six programs used in this analysis (Table 1) are
NSAPD,4 Prince Edward Island Reproductive Care Pro-
gram,5 Newfoundland and Labrador Provincial Perinatal
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ABBREVIATIONS
APHP Alberta Perinatal Health Program
BCPHP British Columbia Perinatal Health Program
CMDS Canadian Minimal Dataset
CPN Canadian Perinatal Network
CPPC Canadian Perinatal Programs Coalition
MgSO4 Magnesium sulfate
Niday Niday Perinatal Database (Ontario)
NLPPP Newfoundland and Labrador Provincial Perinatal Program
NSAPD Nova Scotia Atlee Perinatal Database
PEIRCP Prince Edward Island Reproductive Care Program
PHP Perinatal health program
Program,6 Niday Perinatal Database (Ontario),7 Alberta
Perinatal Health Program,8 and British Columbia Perinatal
Health Program.9 The data from Whitehorse (Yukon) are
collected using the BCPHP database platform but are
housed in their own separate territorial database.9
Table 2 (demographics) shows that while all programs col-
lect maternal and infant personal identifiers, only two docu-
ment ethnicity: Niday, in Ontario, which only defines
aboriginal status and NSAPD, in which ethnicity is a
non-mandatory field, report some form of personal identi-
fier for both mother and baby. Maternal chart number is
documented by all PHPs, with the most recent addition
being Niday in 2004. Personal health numbers are collected
by four PHPs (PEIRCP, NSAPD, NLPPP, and BCPHP),
the CMDS, and CPN. All PHPs gather socioeconomic
status and body mass index data, while lone parent status is
collected by four PHPs. CPN collects most maternal and
infant identifiers, ethnicity (not mandatory), and other
demographics listed in Table 2.
Table 3 (past medical, obstetric, and surgical history) shows
most PHPs document previous diabetes mellitus, miscar-
riages or terminations, perinatal deaths, or Caesarean sec-
tions. While the data fields are similar, many definitions are
different. For example, pre-existing hypertension is defined
by CPN as “a blood pressure of 140/90 or greater at least
twice before pregnancy or before 20 weeks’ gestation”3;
NSAPD defines pre-existing hypertension as “documenta-
tion that would indicate hypertension was a diagnosis or
present before pregnancy”4; while NLPPP uses only the
ICD-10-CA code (010). Most PHPs that collect parity also
differ in the style of collection; PEIRCP and NLPPP
OBSTETRICS
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Table 1. Canadian perinatal health programs
Variables RCPNS (NS) PEIRCP (PEI) NLPPP (NL) Niday (ON) APHP (AB) BCPHP (BC)*
Program
established
1973 1984 1979 1997 1992 1988
Database
established
1988 (NSAPD) 1990 2001 1997 1992 1994
Version used
in this analysis
Apr 2007 2007 Oct 2007 Nov 2006 Oct 2007 Apr 2008
Population All pregnancies†
and births in NS
All pregnancies‡§ All pregnancies‡
and births in 2
health authorities
All births in ON¶ All births in AB All births in BC
Deliveries/yr in
database
8500 (2006) 1400 (2005) 2800 (2002) 125 000 (2006/07) 45 200 (2006) 42 000 (2007)
Website http://rcp.
nshealth.ca
http://www.gov.
pe.ca/health
http://www.
nlppp.ca
https://www.niday
database.com
http://www.aphp.ca http://www.
bcphp.ca
CIHI data
included?
Yes No Yes No No Yes
RCPNS: Reproductive Care Program of Nova Scotia
*The BC Perinatal Database is also used by Yukon.
†Includes only pregnancies reported after 20 weeks gestation.
‡Includes babies born to Nova Scotia residents.
§Includes babies born to Prince Edward Island residents.
Includes Children’s and Women’s Health Program of Eastern Health.
¶In 2006/2007, 95% of births in Ontario.
Table 2. Demographics
Variables
PHPs that collect
the information
(N = 6) CMDS CPN
Maternal personal identifiers
(one or more)
6  
Hospital chart number 6 
Provincial health number 4*  
Mother’s first/last name 3 
Mother’s date of birth 6  
Other† 4 
Infant(s) personal identifiers
(one or more)
6  
Hospital chart number 5  
Provincial health number 4
Infant’s first/last name 3 
Date of birth 6  
Ethnicity 2‡ §
Language spoken 1
Socioeconomic status 6 
Lone parent 4  
BMI (calculated from pre-
pregnancy height and weight)
6  
BMI: body mass index.
*Includes NLPPP, PEIRCP, NSAPD, and BCPHP.
†Some programs collect information about street address, city, health
region, province, country of residence (as opposed to place of birth).
‡Niday collects information on Aboriginal status (First Nations, Métis, Inuit),
while NSAPD collects non-mandatory information about the following races
or ethnicities: Acadian, African-Canadian, Asian, Caucasian,
First Nations, Hispanic, Jewish, Mediterranean, Middle Eastern,
Québécois, other.
§CPN collects information on broad categories, but the information
is not mandatory.
Socioeconomic status is defined by education, occupation, and/
or postal code.
calculate parity as (gravidity—[elective terminations +
miscarriages]). BCPHP records parity as  1 if any of
previous term + preterm births, previous vaginal
deliveries + previous Caesarean deliveries, or living chil-
dren is greater than 0. Other PHPs such as NSAPD and
CPN calculate parity by totalling the previous number of
stillbirths and live births, while APHP collects parity as
gravida— abortions—1 (for the current pregnancy). Previ-
ous stillbirths are collected by most PHPs and are consis-
tently defined as the complete expulsion or extraction from
its mother after at least 20 completed weeks gestation or
after attaining a weight of at least 500 g, of a product of con-
ception in which, after the expulsion or extraction, there is
no breathing, cardiac activity, pulsation of the umbilical
cord, or unmistakable movement of voluntary muscle. The
only PHP that uses a different definition of stillbirth is
Niday, which defines stillbirth as occurring at greater than
20 weeks, though the Niday system will allow births of
18–20 weeks. Preterm birth is documented by all PHPs,
CPN, and the CMDS; however, definitions vary: most
include babies born at < 37 weeks’ gestation (CPN,
PEIRCP, NLPPP, BCPHP), while others such as NSAPD
use LMP, ultrasound dating, and infant clinical assessment
to define preterm birth (although < 37 weeks is the most
common definition). Few PHPs document other previous
medical complications (e.g., gestational diabetes mellitus or
gestational hypertension). This pattern of data collection is
reflected by CMDS. CPN collects more detailed previous
medical and obstetric complications relevant to the major
determinant of very preterm birth.
Table 4 (current pregnancy) shows limited reporting on
most variables by all programs. All PHPs, CMDS, and CPN
collect information regarding expected date of confinement
and multiple pregnancies. Although lifestyle choices, such
as tobacco, alcohol, and illicit drug use, are documented by
all PHPs, they differ in the data fields and the amount of
detail they collect. For example, most collect the number of
cigarettes per day in pregnancy, but only two PHPs (Niday
and PEIRCP) and the CMDS specify whether or not there
was smoking before or after 20 weeks. Moreover, only two
PHPs (PEIRCP and NLPPP) and the CMDS document
exposure to environmental tobacco, and only the CMDS
collects nicotine replacement therapy. The same trend
applies with alcohol; while all PHPs, the CMDS, and CPN
collect alcohol or illicit drug use in the pregnancy, only two
PHPs, the CMDS, and CPN collect the amount of alcohol
used (e.g., bingeing, or > 3 drinks/day), while NSAPD col-
lects only alcohol abuse without being any more specific.
Only three PHPs, the CMDS, and CPN specify which illicit
drugs are used (e.g., opiates, cannabis, cocaine, hallucino-
gens, stimulants, solvents). Many PHPs collect information
on the nature of prenatal care and type of provider, as does
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Table 3. Past medical/obstetric/surgical history
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Medical history
Pre-existing hypertension 5  
Diabetes mellitus 5  
Thromboembolism 2 
Thrombophilia 2 
Other* 4
Previous blood transfusion 1
Obstetric/gynaecological history
Gravidity 4  
Parity 5  
Reported directly 1
Calculated 4  
Spontaneous abortions 2  
Elective terminations 2  
Abortions
(spontaneous and therapeutic)
5  
Uterine structural abnormalities 3 
Prior obstetric history
Previous congenital anomalies 2
Previous stillbirth 5  
Previous neonatal death 5 
Previous preterm delivery 6  
Previous low
birthweight infant
5  
Previous GH 1 
Previous PPROM 0 
Previous GDM 3 
Previous Caesarean section 6  
Previous postpartum
depression
3
Date of last pregnancy 0 
Date of last delivery 1 
GDM: gestational diabetes mellitus; GH: gestational hypertension; PPROM:
preterm pre-labour rupture of membranes.
*NSAPD, PEIRCP, and BCPHP include data from CIHI for ICD codes which
report on disease in the following systems: pulmonary, heart, renal,
endocrine, and gastrointestinal, in addition to blood dyscrasias, neurological
illness, neoplasms, and psychiatric illness.
the CMDS, however this is rarely collected by CPN. Fewer
PHPs (BCPHP and PEIRCP) collect Rh immunoglobulin
(given antenatally or postpartum).
Table 5 (maternal complications and interventions) shows
that few interventions other than maternal transport, blood
transfusion, and corticosteroids are collected by the PHPs
consistent with the CMDS. These interventions are the
focus of CPN data collection, which focuses on a high-risk
population as opposed to normal pregnancies. For exam-
ple, while antibiotic use is collected by three PHPs and
CPN, the PHPs document only whether or not antibiotics
were given antepartum, intrapartum, or postpartum; they
do not collect type or dosing, all of which are captured by
CPN. Also, while MgSO4 is collected by CPN in detail
(type, route, indication, timing, and date), NSAPD and
PEIRCP capture these data only when MgSO4 is used as a
generic antihypertensive or anticonvulsant, or to stop
preterm labour.
While all PHPs, the CMDS, and CPN collect use of
corticosteroids, they all capture it slightly differently. The
PHPs collect yes/no for corticosteroids. PEIRCP,
NSAPD, Niday, MDS, and CPN also identify whether the
course was complete or partial. Some PHPs collect type of
corticosteroid; NSAPD and PEIRCP collect dexametha-
sone or betamethasone, while CPN collects all types. The
CMDS and CPN also collect timing, time of first dose, and
whether administration was antepartum, intrapartum, or
postpartum. In addition, CPN collects indication for drug
initiation and route of administration. Most PHPs gather
information on gestational hypertension, gestational
diabetes mellitus, antepartum hemorrhage, group B strepto-
coccus, chorioamnionitis, hepatitis B, HIV, and urinary
tract infections in the current pregnancy.
Table 6 (fetal complications and interventions) demon-
strates that half of the PHPs collect basic fetal complica-
tions, none of which are proposed in the CMDS. These
complications and interventions are the focus of CPN data
collection.
Table 7 (labour and delivery) shows that basic variables are
well-documented by all PHPs, although details such as
induction of labour and delivery modes may differ.
Neonatal data collected are listed in Table 8. All programs
collect neonatal mortality and major morbidities.
DISCUSSION
The current landscape of Canadian provincial perinatal data
collection covers a wide variety of information; this basic
surveillance allows for sufficient information to oversee
trends in birth outcomes and in interventions. The factors
that are collected most frequently by provincial PHPs are
OBSTETRICS
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Table 4. Current pregnancy
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Prenatal care
Date of first visit 5 
No. visits in pregnancy 2 
Attendance at
classes/education
4 
Antenatal care provider 4 
Type* 3 
Reproductive assistance 3
Expected date of confinement 6  
According to LMP 4 
According to ultrasound 1 
Details of first trimester
ultrasound†
1
Multiple pregnancy 6  
Type of twins 2 
Prenatal diagnosis
Maternal serum screening 4 
Nuchal translucency 2
Amniocentesis 3 
Chorionic villous sampling 3 
Uterine artery Doppler
velocimetry
1 
Routine prenatals
Rubella immune 2 
Blood type 2 
Rh type 1
Third trimester maternal
hemoglobin
2
Maternal “antibody conditions”‡ 3
Lifestyle§
Weight gain in pregnancy 5  
Smoking 6  
Alcohol in pregnancy 6  
Illicit drug use 6  
LMP: last menstrual period.
*Includes family physician, midwife, nurse practitioner, registered nurse,
obstetrician, other, or none.
†NSAPD reports on crown/rump length or biparietal diameter, head
circumference, abdominal circumference, and femur length.
‡These are reported only by NSAPD, and comprise a mixture of
allo-antibodies (to many red blood cell antigens including Rh and “PL-A1
Platelet antigen negative”), auto-antibodies (ANA, anti-DNA, anti-SSA, and
anti-SSB), and thrombophilias (i.e., Factor V Leiden mutation, anticardiolipin,
lupus anticoagulant).
§Defined as non-heritable factors that may affect pregnancy.
Calculated from pre-pregnancy weight and either pre-delivery weight or
admission weight.
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Table 5. Maternal interventions and complications
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
General interventions
Transport
Reason for transport 1
Transferring hospital 4  
Receiving hospital 3  
Expectant management 0 
Outpatient surveillance
program*
0 
Blood transfusion 4  
Drug therapy
Preconceptual folate 2
Preventative therapies 0 
Corticosteroids 6  
Antihypertensives 3 
MgSO4† 2 
Anticonvulsants 1 
Tocolytics 3 
Antibiotics 3 
Other (list) 3 
ICU admission 1 
Self-measurement of BP 0 
Preterm labour‡
Fetal fibronectin testing 0 
PPROM‡ 0 
Short cervix‡ 0 
Prolapsing membranes 0 
Cervical surveillance 0 
Cervical cerclage§ 2 
GH‡ 5  
HELLP syndrome 3  
Eclampsia 3  
Highest systolic BP 1 
Highest diastolic BP 1 
Worse dipstick
proteinuria antenatally
0 
24hr urine collection
proteinuria (g/d)
1 
Antepartum hemorrhage* 4  
Due to placental previa 3  
Due to placental
abruption
3  
Due to another cause 4 
GDM 5 
Fever 2 
Infections
Table 5. Continued
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Obstetric
GBS infection or
colonization
5  
Chorioamnionitis 4  
Other
Hepatitis A 2
Hepatitis B 4  
Hepatitis C 3  
HIV 5  
Herpes simplex
genitalis
3  
Varicella zoster 2 
CMV 2 
Tuberculosis 1
UTI 4  
STD¶ 3  
Other (list) 3  
Abdominal inflammation/
surgery
3 
Coagulopathy 3
BP: blood pressure; CMV: cytomegalovirus; GBS: group B streptococcus;
GDM: gestational diabetes mellitus; GH: gestational hypertension;
HELLP: hemolysis, elevated liver enzyme, low platelet syndrome;
HIV: human immunodeficiency virus; ICU: intensive care unit;
PPROM: preterm pre-labour rupture of membranes; STD: sexually
transmitted disease; UTI: urinary tract infection
Maternal outpatient intensive surveillance care: antepartum home care,
obstetrical day unit visit(s), or other (specify the type of care received,
e.g., visits from home care nurse). Routine antenatal care, including
outpatient clinic visits, is NOT intensive outpatient surveillance.
†Listed as an antihypertensive drug in BCPHP, therefore not distinguishable
as a treatment for hypertension.
‡These are indications for enrolment in CPN; dates of onset and hospital
admission are recorded.
§NSAPD and PEIRCP collect this as coded data from CIHI. CPN collects the
following cerclage information: timing (elective or rescue, before or during
admission), type (McDonald [transvaginal], Shirodkar [transvaginal],
transabdominal, or unknown), and removal (when PPROM diagnosed, when
APH diagnosed, with onset of labour, electively at 36 weeks, or at or after
delivery).
Infections collected by BCPHP are postpartum wound infections, blood
culture agents, and other agents. These are coded, so may not necessarily
be coded as a standard. (Testing for hepatitis B, HIV, and UTIs is standard
with BCPHP).
¶Chlamydia, gonorrhea, syphilis, bacterial vaginosis, human papillomavirus.
population-based data: demographics (both maternal and
neonatal, including personal identifiers), past obstetrical
history, maternal lifestyle, labour and delivery, and basic
neonatal outcomes.
Ethnicity (Table 2) is documented by only two PHPs and
CPN (non-mandatory). This de-emphasis reflects varying
perceptions about ethnicity and continued debate about its
significance with respect to health. Today, ethnicity is com-
monly defined as self-identification with a culture (if any) of
which individuals consider themselves to be a part. As such,
ethnicity becomes subjective, making it almost impossible
to relate ethnicity data as collected to specific genetic risks
that correlate with ethnicity defined by genetic
polymorphisms. As our population becomes more ethni-
cally heterogeneous, ethnicity becomes less of a discernible
predictor of health status. Rather, the cultural implications
of ethnicity become more significant.10 Even if it were
advantageous to use ethnicity as an indicator, large data-
bases do not have the facility to collect this information,
because of the complexities noted above. Although the
paucity of ethnicity data in the various Canadian PHP data-
bases appears justified, we do need variables that denote
socioeconomic status and lifestyle, such as beliefs, diet, and
support.
Including personal identifiers in databases allows for confir-
mation of data, updates, corrections or improvements, and
perhaps definitive linkage to other provincial or national
databases. In this analysis, all of the PHPs, the CMDS, and
CPN allow for this. On the other hand, a patient’s health
number or name allows for linkages to other identifiers,
which could lead to other information and networks such as
laboratory results at other facilities or other provincial or
national networks. In this case, only PEIRCP, NLPPP,
NSAPD, BCPHP, CMDS, and CPN collect this
information.
Because it includes only the direct variables collected by the
programs, the current study is limited by not accounting for
the potential linkages that databases could have with other
resources for additional information using personal identi-
fiers. For example, PHPs could potentially link a patient to
other databases to receive laboratory results, prescriptions
filled by pregnant women, or details of newborn screening
and immunization. This could also allow for longitudinal
linkages that would connect to educational or environ-
mental databases for long-term outcomes.
Our analysis shows that the CPN database was needed to
collect detailed information on interventions. Within most
PHPs there are insufficient data with respect to obstetric
(and neonatal) practices to enable the identification of prac-
tices associated with good or poor maternal or perinatal
outcomes. For example, PHP data, if more were collected,
could be used to determine the optimal type of antibiotic
for PPROM. Specifically, no PHPs have detailed informa-
tion about outpatient surveillance programs (Table 4), while
the use of MgSO4 is only specifically named in two PHPs
(PEIRCP and NSAPD). This is despite the grade I-A rec-
ommendation of use of MgSO4 in the Canadian,11 US
(NHBPEP 2000),12 and Australian (ASSHP 2000)13 guide-
lines for management of the hypertensive disorders of preg-
nancy, and, therefore, an auditable standard for provincial,
national, and international benchmarking. When databases
label MgSO4 as an antihypertensive, it means that the use of
an effective intervention cannot be assessed in that
jurisdiction.
The variability between PHP databases is recognized by the
CPPC, which proposed the CMDS as a first step towards
harmonization, time and budgetary constraints allowing.
While many PHPs collect similar information, many collect
information in various ways (e.g., direct versus calculated
parity) or have different definitions (e.g., for preterm deliv-
ery or pre-existing hypertension).
It must be recognized that no database can be all things to
all people. The PHPs aim to monitor trends over time, eval-
uate guidelines, and identify issues that require further
attention or are appropriate for epidemiological and other
research. Identifying geographical clusters of risk factors
for targeting health care actions is a powerful tool for effec-
tive interventions,14 as PHP population cohorts represent
the general maternity population. The PHPs should also
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Table 6. Fetal complications and interventions
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
IUGR* 3 
Antenatal surveillance† 4 
Polyhydramnios 4 
Amnioreduction 2 
Oligohydramnios 4 
Amnioinfusion 3 
Other procedures‡ 3 
IUGR: intrauterine fetal growth restriction
*These are indications for enrolment in CPN; dates of onset and hospital
admission are recorded.
†Includes one or more of cardiotocography, amniotic fluid volume,
biophysical profile, umbilical artery Doppler velocimetry, middle cerebral
artery Doppler, ultrasonographic estimated fetal weight, and fetal lung
volume (with PPROM) by ultrasound or MRI.
‡Includes one or more of amnion septostomy, bladder shunt, cord
occlusion, intrauterine transfusion, laser surgery, multi-fetal reduction,
pleuroamnio shunt, open fetal surgery, fetal blood transfusion, fetal
drainage, fetal stent placement, cordocentesis.
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Table 7. Labour and delivery
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Length of stay* 5 
Admission number 5
Induction of labour
Indication 6 
Method (list) 6  
N induction attempts 2
Labour augmentation 6  
Method (list) 4
ROM
Spontaneous/artificial 3 
Date/time 5  
Fetal presentation 6  
1st stage of labour
Duration of 1st stage 5 
Rate of dilatation for 1st stage† 2
General tract and perineal trauma‡ 5 
2nd stage of labour duration 6 
3rd stage of labour duration 4
Fetal surveillance in labour
Scalp pH 2
Meconium staining 4 
Shoulder dystocia 3 
Analgesia/anaesthesia 6  
Type
None 6  
Narcotics (includes PCA
pump)
5  
Nitrous oxide 3  
Local anaesthetic
(e.g., pudendal block)
5  
Regional (epidural, spinal,
or spinal-epidural)
5  
General 5  
Other 6  
Unknown 2  
Table 7. Continued
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Maternal complications of
anaesthesia
3
Mode of delivery 6  
Vaginal 6  
Forceps/vacuum 5  
VBAC 5
Caesarean section 6  
Indications for
Caesarean section
3 
Type 6  
Cervical dilatation
at Caesarean section
3
Intrapartum blood loss 3
Type of caregiver who
delivered¶
5 
Mother’s discharge
disposition (home, transfer,
unknown) alive/dead
4  
PCA: patient controlled analgesia; VBAC: vaginal birth after Caesarean
section.
*Calculated by day of discharge - day of admission or date and time of
discharge - date and time of birth. This refers to delivery admission, except
for CPN which also refers to other antepartum admissions. NSAPD and
NLPPP also have the capability to collect antepartum admissions prior to
delivery admissions.
Rate = (cervical full dilatation - dilatation at admission) /
(time at full dilatation - time at admission)
Episiotomy, laceration, or cervical tear.
External/internal and intermittent/continuous FHR monitoring, auscultation
of FHR, scalp pH.
Includes non-pharmacological methods such as transcutaneous nerve
stimulation, hypnosis, acupuncture, aromatherapy, New Age, and deep
breathing or meditation techniques.
¶GP, obstetrician, RN, midwife, nurse practitioner, resident, other MD,
paramedic, at home, surgeon, or no attendant.
OBSTETRICS
244  MARCH JOGCMARS 2009
Table 8. Perinatal outcomes
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Outcome
Termination of
pregnancy
0 
Stillbirth 6  
Live birth 6  
Neonatal death 6  
For neonatal death
Age at death* 3  
Autopsy 3 
Cause 3  
Gestational age 6  
Neonatal
Meconium aspiration 3 
Fracture 3 
Cord blood gases
pH 5  
Base excess 5  
pCO2 2 
Apgar scores
1 minute 6 
5 minutes 6 
10 minutes 4 
Vitamin K administered 2
Resuscitation/ventilation 6  
Admission to hospital 3
Gender 5  
Rh type 1
Blood group 1
Anthropomorphic
measurements
Birthweight 5  
Length 4 
Head circumference 6 
Major Congenital anomaly† 4  
Chromosomal abnormality 3 
Neonatologist 2
Admission to NICU 6 
TRIPS score 1
SNAP II score 1
Length of stay (days)‡ 5 
Mechanical ventilation
& mode
5 
Total parenteral
nutrition
3 
Transfusion 2 
Complications of
prematurity§
4  
Table 8. Continued
Variables
PHPs that
collect the
information
(N = 6) CMDS CPN
Procedures 3 
Complications of
procedures
3
Central venous
catheter(s)
1 
Infant medications 2 
Other neonatal complications¶ 4  
Infant feeding
Mother’s intention to
breastfeed
5
Early breast contact 2
Infant feeding (type) 5 
Reason for substitute 2
Jaundice/phototherapy 3
Newborn screening & type 1
Immunizations 1
Discharge disposition
Details of transfer# 4  
Needed home oxygen 2
Neonatal Follow-up clinic 1
NICU: neonatal intensive care unit; SNAP: score for neonatal acute
physiology; TRIPS: temperatory, respiratory status, systolic BP, response to
noxious stimuli.
*Can be calculated by date of death—date of birth.
†Specific list from Niday and CMD includes: anencephaly, spina bifida,
meningocele, myelomeningocele, hydrocephaly, cleft lip, cleft palate, Down
syndrome, neural tube defect, defects of CNS, GI, renal, respiratory,
cardiovascular, or musculoskeletal systems, and other. BCPHP, PEIRCP, and
NSAPD code others, while APHP records Y/N. CPN has a field to enter the
data.
‡Calculated from discharge date - admission date.
§BPD (bronchopulmonary dysplasia) or CLD (chronic lung disease), ROP
(retinopathy of prematurity), severe IVH (intraventricular hemorrhage), NEC
(necrotizing enterocolitis), HIE (hypoxic-ischemic encephalopathy)/
convulsions/seizures, or neonatal sepsis.
Laparotomy, thoracotomy, craniotomy, ECMO (extracorporeal membrane
oxygenation).
¶Includes fetal malnutrition/soft tissue wasting, patent ductus arteriosus,
pulmonary hypertension of newborn, respiratory distress syndrome, birth
asphyxia sequelae, and neoplasms.
#Includes at least two of the following; date, time, destination, and reason for
transfer.
ensure that there is equal emphasis on determinants of
health and on interventions, such as the grade I-A recom-
mendations outlined by clinical practice guidelines. The
PHPs would then be in a position to audit and validate rec-
ommendations in larger jurisdictions. Examples of grade
I-A recommendations that PHPs cannot report on are the
CMDS’s lack of prenatal diagnosis or routine prenatal
bloodwork. According to Summers et al., all pregnant
women in Canada should be offered prenatal screening and
second trimester ultrasound for dating growth and anoma-
lies.15 Similarly, Keenan-Lindsay and Yudin have advised
that all women should be offered HIV screening at their
first prenatal visit (I-A)16; however, APHP and NLPPP do
not collect this information. Moreover, the use of MgSO4 as
prophylaxis against, and treatment of, eclampsia in women
with severe preeclampsia (I-A17) is only collected by
NSAPD and PEIRCP (as a yes/no question). Every PHP
collects information about antenatal corticosteroid use.
The challenge begins now that researchers and PHPs have
started to become interested in interprovincial and national
comparisons, especially with the electronic health record on
the horizon. While the shift to electronic health records will
be the main stimulus driving standardization of data defini-
tions, PHPs will influence what data fields are collected.
Because most PHPs influence, revise, and create the ante-
natal, perinatal, and labour and delivery forms, electronic
vendors will be seeking advice and expertise from the PHPs
as to which data to include in electronic health records.
CONCLUSION
Variations in language across perinatal databases are a great
challenge that all local, provincial, and national organiza-
tions will eventually have to overcome. The future direction
is towards a standardized language on which all databases
and the electronic health record will be based. Standardized
definitions will allow for data sharing supplemented by spe-
cific, focused data collection. The CPPC, through the
CMDS, has started to tackle this issue. Converging with the
new language of the electronic health record, SNOMED
CT (Systematized Nomenclature of Medicine—Clinical
Terms) will be the next step.
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Principal
Investigator
(CIHR)
Co-Investigator
(CIHR)
Steering
Committee
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(Site
Investigators)
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Mark Ansermino BC Children’s Hospital, Vancouver BC  
François Audibert Hôpital Sainte-Justine, Montréal QC  
Jon Barrett Women’s College Hospital, Toronto ON  
Emmanuel Bujold Centre Hospitalier de l’Université Laval (CHUL),
Québec QC
 
Craig Burym St. Boniface General Hospital, Winnipeg MB
Winnipeg Health Science Centre, Winnipeg MB

George Carson Regina General Hospital, Regina SK 
Joan Crane Women’s Health Program, Eastern Health,
St. John’s NL
 
Jerome Dansereau Victoria General Hospital, Victoria BC 
Nestor Demianczuk Royal Alexandra Hospital, Edmonton AB  
Duncan Farquharson Royal Columbian Hospital, New Westminster BC 
Rob Gratton (pending) Saint Joseph’s Health Centre, London ON 
Shoo Lee iCARE, University of Alberta, Edmonton AB  
Robert Liston BC Women’s Hospital, Vancouver BC   
Laura Magee BC Women’s Hospital, Vancouver BC   
Angela Mallozzi
(pending)
Royal Victoria Hospital, Montréal QC 
Sarah McDonald
(pending)
McMaster University Medical Centre, Hamilton ON 
Jean-Marie Moutquin Centre Hôspitalier Universitairé de Sherbrooke,
Sherbrooke QC

Femi Olatunbosun Royal University Hospital, Saskatoon SK 
Jean-Charles Pasquier Centre Hôspitalier Universitairé de Sherbrooke,
Sherbrooke QC

Bruno Piedboeuf Centre Hospitalier de l’Université Laval, Québec QC  
Frank Sanderson
(pending)
Saint John Regional Hospital, Saint John NB 
Graeme Smith Kingston General Hospital, Kingston ON   
Peter von Dadelszen BC Women’s Hospital, Vancouver BC   
Mark Walker The Ottawa Hospital, Ottawa ON   
Wendy Whittle Mount Sinai Hospital, Toronto ON  
Liz Whynot BC Women’s Hospital & Health Centre, Vancouver BC 
Stephen Wood Foothills Medical Centre, Calgary AB 
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